Staff costs by isolation of MRSA patients;Personalkosten durch isolierungsmaßnahmen von MRSA-patienten

Gesundheitsokonomie und Qualitatsmanagement

Volumn 8, Issue 3, 2003, Pages 187-190

  Popp, Walter ^a   Hilgenhoner M ^a   Leisebein, T ^a   Muller H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bed blocking; Costs; DRG; Isolation; MRSA

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CALCULATION; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSIS RELATED GROUP; GERMANY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HOSPITAL BED; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INCOME; ISOLATION PROCEDURE; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT CARE; STAFF; TIME;

EID: 0042326155     PISSN: 14322625     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40481     Document Type: Article

References (10)

1. Abramson MA, Sexton DJ. Nosocomial Methicillin-resistant and Methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20: 408-411
2. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus. JAMA 1999; 282: 1745-1751
3. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylocccus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995; 29: 87-106
4. Geldner G, Ruoff M, Hoffmann H-J, Kiefer P, Georgieff M, Wiedeck H. Eine Kostenanalyse von MRSA-Infektionen auf einer operativen Intensivstation. Anästhesiol Intensivmed Notfallmed Schmerzther 1998; 34: 409-414
5. Mehtar S, Drabu YJ, Mayet F. Expenses incurred during a 5-week epidemic methicillin-resistant Staphylococcus aureus outbreak. J Hosp Infect 1989; 13: 199-203
6. Meltzer MI. Introduction to health economics for physicians. Lancet 2001; 358: 993-998
7. Palau E. Implication of methicillin-resistant Staphylococcus aureus for hospital management and public relations. In: Coello R, et al (eds.). Methicillin-resistant Staphylococcus aureus. Kent: Wells Medical Ltd., 1993: 67-70
8. RKI. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus (MRSA)-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen, Bundesgesundhbl 1999; 42: 954-958
9. Rubin RJ, Harrington CA, Poon A. Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York hospitals. Emerg Infect Dis 1999; 5: 9-17
10. Working Party Report. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals J Hosp Infect 1998; 39: 253-290